ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Columbus, OH

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Type 2 Diabetes Mellitus
Diabetes Mellitus
Obesity
Type 1 Diabetes Mellitus
Overweight
Diabetic Foot
Foot Ulcer

Diabetes trials near Columbus, OH, USA:

Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes (ReCET)

This study is designed to evaluate the safety and effectiveness of endoscopic intestinal re-cellularization therapy in individuals with type 2 diabetes...

Enrolling
Diabetes
Type2diabetes
Device: ReCET Treatment
Device: Sham Procedure
Endogenex

Columbus, Ohio, United States and 44 other locations

care (prenatal visits, self-monitored blood glucose, and certified diabetes care and education specialist) on achieving glycemic control (he...

Enrolling
Type2diabetes
Pregnancy in Diabetic
Device: DEXCOM G7 PRO Continuous Glucose Monitor
Device: Patient mHealth app linked to a provider dashboard
The Ohio State University
The Ohio State University

Columbus, Ohio, United States

The purpose of this study is to assess the safety and tolerability of aleniglipron at doses up to 240 mg once daily (QD) in participants with T2DM wh...

Active, not recruiting
Obesity Type 2 Diabetes Mellitus
Weight Loss
Drug: Placebo
Drug: Aleniglipron

Phase 2

Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics

Columbus, Ohio, United States and 15 other locations

This is a multicenter, randomized, placebo-controlled, 2-part study to evaluate the safety and efficacy of AT-001 in adult patients (N=675) with Diabetic...

Active, not recruiting
Diabetic Cardiomyopathies
Drug: AT-001
Drug: Placebo

Phase 3

Applied Therapeutics

Columbus, Ohio, United States and 78 other locations

This is randomized, double-blind, placebo-controlled study of the long-term efficacy, safety, and tolerability of multiple doses of aleniglipron in p...

Begins enrollment this month
Type2 Diabetes Mellitus
Overweight
Drug: Placebo
Drug: aleniglipron

Phase 3

Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics

Columbus, Ohio, United States and 73 other locations

the treatment with the COMS One device in subjects with refractory diabetic foot ulcers (DFUs). The prospective randomized, double-blinded, ...

Enrolling
Diabetic Foot Ulcer
Device: COMS One device
Device: Sham device
Piomic Medical

Columbus, Ohio, United States and 28 other locations

The purpose of this study is to assess the safety and efficacy of SkinTE for treatment of Wagner grade 1 diabetic foot ulcers....

Active, not recruiting
Diabetic Foot
Biological: SkinTE
Other: Control

Phase 3

PolarityTE

Grove City, Ohio, United States and 22 other locations

CAPTAIN-T2D will take place in two parts. Part 1 (Screening) will evaluate patients with type 2 diabetes and elevated cortisol risk factors ...

Enrolling
Type 2 Diabetes
Cortisol Excess
Drug: clofutriben
Drug: Placebo

Phase 2

Sparrow Pharmaceuticals

Columbus, Ohio, United States and 60 other locations

allograft, and/or Amnion/Amnion allograft, plus Standard of Care (SOC) each versus SOC alone in the treatment of chronic non-healing diabetic...

Enrolling
Diabetic Foot Ulcer (DFU)
Chronic Foot Ulcers
Other: Allograft
Tides Medical

Circleville, Ohio, United States and 8 other locations

standard of care, improves healing outcomes in patients with chronic diabetic foot ulcers.Diabetic foot ulcers are a common and ser...

Enrolling
Diabetic Foot
Diabetic Foot Ulcers (DFUs)
Device: Miro3D Wound Matrix
Other: Standard of Care
Reprise Biomedical, Inc.

Columbus, Ohio, United States and 13 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems